Legal & General Group Plc Has $24.94 Million Position in Globe Life Inc. $GL

Legal & General Group Plc lifted its position in shares of Globe Life Inc. (NYSE:GL) by 11.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 178,297 shares of the company’s stock after purchasing an additional 18,104 shares during the period. Legal & General Group Plc’s holdings in Globe Life were worth $24,937,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of GL. Allianz Asset Management GmbH lifted its position in Globe Life by 55.2% during the third quarter. Allianz Asset Management GmbH now owns 82,263 shares of the company’s stock worth $11,761,000 after acquiring an additional 29,256 shares during the last quarter. Retirement Systems of Alabama acquired a new position in shares of Globe Life in the third quarter valued at about $2,470,000. Pzena Investment Management LLC increased its holdings in shares of Globe Life by 5.6% during the third quarter. Pzena Investment Management LLC now owns 998,506 shares of the company’s stock worth $142,756,000 after purchasing an additional 52,523 shares during the period. SG Americas Securities LLC lifted its position in shares of Globe Life by 909.6% during the 4th quarter. SG Americas Securities LLC now owns 99,746 shares of the company’s stock valued at $13,950,000 after acquiring an additional 89,866 shares during the period. Finally, Tudor Investment Corp ET AL acquired a new position in Globe Life in the third quarter valued at about $7,348,000. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Globe Life

In other Globe Life news, CEO James Matthew Darden sold 18,318 shares of the firm’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $145.10, for a total value of $2,657,941.80. Following the completion of the sale, the chief executive officer owned 51,093 shares of the company’s stock, valued at approximately $7,413,594.30. This trade represents a 26.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Thomas Peter Kalmbach sold 15,637 shares of Globe Life stock in a transaction on Monday, May 11th. The shares were sold at an average price of $153.65, for a total transaction of $2,402,625.05. Following the completion of the sale, the chief financial officer directly owned 45,335 shares of the company’s stock, valued at approximately $6,965,722.75. The trade was a 25.65% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 124,247 shares of company stock worth $19,040,392 in the last three months. Insiders own 2.11% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on GL. Piper Sandler upped their price target on shares of Globe Life from $167.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, May 26th. Evercore set a $157.00 price objective on Globe Life in a report on Wednesday, February 18th. Keefe, Bruyette & Woods reaffirmed a “moderate buy” rating and issued a $168.00 target price on shares of Globe Life in a report on Thursday, March 26th. Weiss Ratings upgraded shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. Finally, Truist Financial lifted their price target on shares of Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a report on Friday, April 24th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $174.11.

Globe Life Stock Performance

Shares of GL opened at $153.46 on Monday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The firm’s fifty day simple moving average is $148.85 and its two-hundred day simple moving average is $142.77. Globe Life Inc. has a 12 month low of $116.73 and a 12 month high of $157.92. The stock has a market capitalization of $11.91 billion, a P/E ratio of 10.61 and a beta of 0.49.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $3.43 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $3.46 by ($0.03). The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.38% and a return on equity of 20.94%. The firm’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.07 earnings per share. Globe Life has set its FY 2026 guidance at 15.400-15.90 EPS. As a group, analysts predict that Globe Life Inc. will post 15.62 EPS for the current year.

Globe Life Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Monday, July 6th will be paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, July 6th. Globe Life’s dividend payout ratio is 9.13%.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.